» Articles » PMID: 4899881

The Enzymatic Termination of Polydeoxynucleotides by 2',3'-dideoxyadenosine Triphosphate

Overview
Specialty Science
Date 1969 Jul 1
PMID 4899881
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The nucleoside 2',3'-dideoxyadenosine is lethal to E. coli and blocks DNA synthesis irreversibly. The hypothesis that a derived dideoxynucleoside triphosphate is incorporated terminally into the cellular DNA has been tested in an in vitro system. The triphosphate of dideoxyadenosine was synthesized and shown to inhibit the in vitro synthesis of DNA by purified E. coli DNA polymerase. The kinetics of inhibition of nucleotide incorporation and pyrophosphate exchange were studied. Early in synthesis the dideoxynucleotide is a competitive inhibitor of the enzyme. Subsequently, synthesis is almost completely arrested.Radioactive dideoxyadenosine triphosphate was prepared. The compound was shown to be incorporated enzymatically into dAT copolymer to the extent of about one molecule per molecule of template. It is released from such templates by DNA polymerase at less than 1 per cent of the rate of release of other natural nucleotides. The label is released by snake venom phosphodiesterase far more rapidly than total nucleotides. This nucleoside triphosphate has thus been shown to be a competitive inhibitor of DNA polymerase and a terminator of polydeoxynucleotide chains.

Citing Articles

Therapeutic Approaches for Zika Virus Infection of the Nervous System.

Abrams R, Solis J, Nath A Neurotherapeutics. 2017; 14(4):1027-1048.

PMID: 28952036 PMC: 5722777. DOI: 10.1007/s13311-017-0575-2.


Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.

Jao J, Abrams E Pediatr Infect Dis J. 2014; 33(7):734-40.

PMID: 24378947 PMC: 4055505. DOI: 10.1097/INF.0000000000000224.


Characterization of a novel DNA polymerase activity assay enabling sensitive, quantitative and universal detection of viable microbes.

Zweitzig D, Riccardello N, Sodowich B, OHara S Nucleic Acids Res. 2012; 40(14):e109.

PMID: 22495933 PMC: 3413125. DOI: 10.1093/nar/gks316.


Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships.

Hoetelmans R, Burger D, Meenhorst P, Beijnen J Clin Pharmacokinet. 1996; 30(4):314-27.

PMID: 8983861 DOI: 10.2165/00003088-199630040-00004.


Antibacterial activity of 2',3'-dideoxyadenosine in vivo and in vitro.

Beskid G, ESKIN B, Cleeland R, Siebelist J, Cappetta A, Hill A Antimicrob Agents Chemother. 1981; 19(3):424-8.

PMID: 6972730 PMC: 181448. DOI: 10.1128/AAC.19.3.424.


References
1.
Robins M, McCarthy Jr J, ROBINS R . Purine nucleosides. XII. The preparation of 2',3'-dideoxyadenosine, 2',5'-dideoxyadenosine, and 2',3',5'-trideoxyadenosine from 2'-deoxyadenosine. Biochemistry. 1966; 5(1):224-31. DOI: 10.1021/bi00865a029. View

2.
McCarthy Jr J, Robins M, Townsend L, ROBINS R . Purine nucleosides. XIV. Unsaturated furanosyl adenine nucleosides prepared via base-catalyzed elimination reactions of 2'-deoxyadenosine derivatives. J Am Chem Soc. 1966; 88(7):1549-53. DOI: 10.1021/ja00959a043. View

3.
Doering A, Jansen M, COHEN S . Polymer synthesis in killed bacteria: lethality of 2',3'-dideoxyadenosine. J Bacteriol. 1966; 92(3):565-74. PMC: 276290. DOI: 10.1128/jb.92.3.565-574.1966. View

4.
Weiss B, Live T, Richardson C . Enzymatic breakage and joining of deoxyribonucleic acid. V. End group labeling and analysis of deoxyribonucleic acid containing single straned breaks. J Biol Chem. 1968; 243(17):4530-42. View

5.
Kornberg A . Active center of DNA polymerase. Science. 1969; 163(3874):1410-8. DOI: 10.1126/science.163.3874.1410. View